Seres Therapeutics
MCRB
#8981
Rank
NZ$0.17 B
Marketcap
$0.98
Share price
-3.90%
Change (1 day)
-19.42%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2023 (TTM): -$1.78

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.99. In 2022 the company made an earnings per share (EPS) of -$4.17 a decrease over its 2021 EPS that were of -$1.30.

EPS history for Seres Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.78-57.2%
2022-$4.17220.55%
2021-$1.30-34.23%
2020-$1.98-15.27%
2019-$2.33-46.09%
2018-$4.339.95%
2017-$3.94-3.49%
2016-$4.08-10.19%
2015-$4.54321.85%
2014-$1.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.81 91.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.03 252.68%๐Ÿ‡บ๐Ÿ‡ธ USA